☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
platform
Kronos Bio Signs a Multi-Year Collaboration with Tempus for Access to its Platform
November 9, 2021
Ziopharm Oncology's Controlled IL-12 Platform Receives EMA's COMP Positive Recommendation for Orphan Drug Designation to Treat Gli...
August 9, 2019
Medtronic Resolute Drug-Eluting Stent (DES) Platform Receives FDA's Approval for Expanded Indication for Chronic Total Occlusion (...
February 27, 2019
Agilent Technologies Acquires ACEA Biosciences to Strengthen Platform and Capabilities in Cell Analysis
September 24, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.